Mr Liviu Titu
Consultant Colorectal and General Surgeon
Medic, MD, FRCS (Gen Surg)
I have been working as Consultant Colorectal and General Surgeon for over eight years. I specialise in minimally invasive procedures such as laparoscopic surgery, robotic surgery and trans-anal endoscopic microsurgery (TEM) to treat bowel cancers, diverticular disease, rectal prolapse and obstructed defaecation.
I offer modern surgery for bowel cancer, haemorrhoids, rectal prolapse, faecal incontinence, disorders of defaecation, diverticular disease, pilonidal sinus disease and all types of hernias. I have one of the largest practices in colonoscopy and endoscopic polypectomy in the North West of England.
I also have a special interest in haemorrhoidal disease, faecal incontinence, irritable bowel syndrome (IBS) and surgery for pilonidal sinus. I have extensive experience in endoscopic removal of large bowel polyps and I am a founding member of the Merseyside and Cheshire Small and Early Rectal Tumours (SERC) MDT and of the Wirral Polyp MDT. I created and chair the Wirral Pelvic Floor MDT, one of the first in the UK.
I have performed over 200 laparoscopic bowel resections for cancer, including over 50 resections for rectal cancer. I also have significant experience with robotic rectal cancer surgery, having already performed 30 such procedures. I perform numerous surgeries for rectal prolapse, of which 25 have been robotic ventral mesh rectopexies, currently the most advanced therapeutic option for rectal prolapse and obstructed defaecation. I have extensive experience with minimally invasive treatment for haemorrhoids and I perform over 100 trans-anal haemorrhoidal dearterialization (THD) with rectal mucopexy yearly. I have extensive experience with colonoscopy and endoscopic polyp treatments, performing in excess of 500 colonoscopies annually, of which over 1/3 are therapeutic.
I constantly audit my results and I am encouraged by the fact that my complication rates are consistently well below the national average for all procedures performed. This is reflected in a short inpatient hospital stay and earlier return to work and normal activities for my patients.
My enduring commitment to improving patient access to diagnosis and treatment for bowel cancer has been recognised by having been entrusted to act as Chair of the Merseyside and Cheshire Colorectal Cancer Clinical Network Group. The group is responsible for developing and promoting colorectal cancer care within the region.
I am Clinical Lead for Colorectal Cancer and Clinical Lead for Pelvic Floor Surgery at Wirral University Teaching Hospital. I introduced and chair the Wirral Pelvic Floor MDT with the aim to offer a multidisciplinary approach to the care of patients presenting with complex pelvic floor conditions: rectal prolapse, faecal incontinence, defaecatory disorders. I am also Clinical Lead for Cancer Services at Wirral University Teaching Hospital, overseeing cancer care and service delivery and development within the trust, working in partnership with primary care and regional stakeholders.
Some of the principal treatments carried out by Mr Liviu Titu at Spire include:
Medic / University of Cluj-Napoca, Romania / 1992
MRCS / Royal College of Surgeons of Edinburgh / 1999
MD / University of Hull / 2003
FRCS / Royal College of Surgeons of Edinburgh / 2005
EBSQ Coloproctology / Munich, Germany / 2010
Eurpean Board of Surgical Qualification Coloproctology
Association of Coloproctology of Great Britain and Ireland
European Society of Coloproctology
The National Pelvic Floor Society
Royal College of Surgeons of Edinburgh
Chair of the Cheshire and Merseyside Colorectal Cancer Network Group
Clinical Lead for Cancer Services, Wirral University Teaching Hospital
Clinical Lead for Colorectal Cancer Surgery, Wirral University Teaching Hospital
Clinical Lead for Pelvic Floor Surgery and Chair of the Pelvic Floor MDT, Wirral University Teaching Hospital
I have authored scientific articles in prestigious surgical journals such as Annals of Surgery, Diseases of Colon and rectum and Colorectal Disease. I was awarded an MD by the University of Hull in 2003 for my thesis “Cytotoxic T cell immune response against telomerase in colorectal cancer patients”. I was supported in my research activities by grants from Cancer Research UK, Bowel Disease Research Foundation, Society of Academic and Research Surgery of Great Britain and Ireland and Yorkshire Cancer Research.
Shapey I, Agbamu D, Newall N, Titu L. Nicorandil associated ulceration of the gastrointestinal tract: side-effects requiring surgical intervention. Int J Colorectal Disease 2015; 30(8):1143-5.
Siddique K, Cheema MR, Bapat P, Titu L. Optimization of Peri-Operative HDU Care for Elective Colorectal Patients. J Women’s Health Care 2014; 3(5):188 doi:10.4172/2167-0420.1000188.
Titu LV, Riyad K, Carter H, Dixon AR. Stapled trans-anal rectal resection (STARR) in the treatment of obstructed defaecation: a cautionary tale. Diseases of Colon and Rectum 2009; 52(10):1716-22.
Titu LV, Phillips SM, Zafar N, Greenslade GL, Dixon AR. Emergency laparoscopic surgery for complicated diverticular disease. Colorectal Disease 2009; 11(4):401-4.
Titu LV, Tweedle E, Rooney PS. High tie of the inferior mesenteric artery in curative surgery for left colonic and rectal cancers: a systematic review. Digestive Surgery 2008; 25(2):148-157.
Titu LV, Breen DJ, Nicholson AA, Hartley JE, Monson JRT. Is routine Magnetic Resonance Imaging justified for the early detection of resectable liver metastases from colorectal cancer? Diseases of Colon and Rectum 2006; 49(6):810-5.
Titu LV, Nicholson AA, Hartley JE, Breen DJ, Monson JRT. Routine follow-up by Magnetic Resonance Imaging does not improve detection of resectable local recurrences from colorectal cancer. Annals of Surgery 2006; 243(3):348-352.
Baker RP, Titu LV, Hartley JE, Lee PW, Monson JR. A case-control study of laparoscopic right hemicolectomy vs. open right hemicolectomy. Diseases of Colon and Rectum 2004; 47(10):1675-9.
Titu LV, Loveday RL, Madden LA, Cawkwell L, Monson JR, Greenman J. Cytotoxic T-cell immunity against telomerase reverse transcriptase in colorectal cancer patients. Oncology Reports, 2004; 12(4):871-6.
Loveday RL, Titu L, Beral D, Jordison V, Monson JRT, Greenman J. Telomerase activity in circulating colorectal tumour cells. Cancer Therapy, 2004; 2:85-90.
Titu LV, Laden G, Purdy GM, Wedgwood KR. Gastric barotrauma in a SCUBA diver: report of a case. Surgery Today 2003; 33(4):299-301.
Titu LV, Monson JRT, Greenman J. Cytotoxic T lymphocyte immunity in colorectal cancer. Cancer Immunology Immunotherapy 2002; 51(5):235-47.
Baker RP, White EE, Titu L, Duthie GS, Lee PWR, Monson JRT. Does laparoscopic abdomino-perineal resection of the rectum compromise long-term survival? Diseases of Colon and Rectum 2002; 45(11): 481-5.
Duca S, Bala O, Iancu C, Titu L, Scripa E. Outcome of Laparoscopic versus Open Cholecystectomy in Obese Patients. Romanian Journal of Gastroenterology 1996; 192(12):323-327.
I am married to Helen and have two daughters, Louisa and Bria. We enjoy holidays in Wales and the south of France and try to stay active by playing tennis, cycling, walking and kayaking along the beautiful Pembrokeshire coast.
|Telephone||0151 929 5408 (Wirral) / 01978268035 (Yale)|
|email@example.com (Wirral) / firstname.lastname@example.org (Yale)|
|Private secretary||Deborah Jones|
|Private secretary telephone||0151 604 7090 extension 2790|
|Private secretary email||Deborah.email@example.com|